Castuner

FLASCO OncoPod

Florida Society of Clinical Oncology

The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected. It’s your go-to source for staying up-to-date on FLASCO’s efforts to support and strengthen the oncology community across Florida.

Podcast website

Listen in your app

Episodes

37 episodes

  1. Empowering the Next Generation of Oncology: SOFLOH & the Fellows and Residents Training Program 18:37
  2. The Nuance in mTNBC | Part 3: Toxicity, Delivery, and the Rest of the Journey 20:12
  3. The Nuance in mTNBC | Part 2: The Patient the Trial Did Not Enroll 15:59
  4. The Nuance in mTNBC | Part 1: Where the Answers Split 15:57
  5. Drew Piers on Advocacy, Storytelling & Shaping the Future of Cancer Care 23:25
  6. The Evolving Management of Hepatocellular Carcinoma: Prevention, Multidisciplinary Care, and Emerging Therapies 29:09
  7. The Evolving Role of Community Oncology: Delivering Academic-Level Cancer Care Close to Home 21:59
  8. Part 4, Advancing Biomarker-Driven Care Through Optimized IHC Testing: Practical Insights on IHC Testing Across Tumor Types 20:01
  9. Part 3, Advancing Biomarker-Driven Care Through Optimized IHC Testing: Practical Insights on IHC Testing Across Tumor Types 15:00
  10. Part 2, Advancing Biomarker-Driven Care Through Optimized IHC Testing: Practical Insights on IHC Testing Across Tumor Types 15:30
  11. Part 1, Advancing Biomarker-Driven Care Through Optimized IHC Testing: Practical Insights on IHC Testing Across Tumor Types 18:43
  12. CLL Treatment Evolution: Rethinking Monotherapy vs Combination Strategies in the Era of Next-Generation BTK Inhibitors 27:51
  13. What's New in Endometrial Cancer: Key Takeaways From SGO 2026 17:30
  14. ASCO Edge and the Future of Oncology Practice Leadership with Dr. Robin Zon ASCO Edge and the Future of Oncology Practice Leadership with Dr. Robin Zon & Dr. Jorge Garcia 13:30
  15. "How I Treat" Micro-Learning Atypical HUS Triggered by Malignancy or Drug Exposure Part 3: Genetics, Duration of Therapy, and Real-World Pearls 7:42
  16. "How I Treat" Micro-Learning Atypical HUS Triggered by Malignancy or Drug Exposure Part 2: Acute Management: TTP vs aHUS and Treatment Decisions 11:11
  17. "How I Treat" Micro-Learning Atypical HUS Triggered by Malignancy or Drug Exposure Part 1: When to Suspect aHUS in Oncology Patients 7:01
  18. Advancing Care in GI and Biliary Tract Cancers Series Episode 4: GEA Disease State and Patient Management; Importance of the MDT 17:58
  19. Advancing Care in GI and Biliary Tract Cancers Series Episode 3: HER2 Agents in GI Cancers - Understanding Mechanisms of Action 19:55
  20. Advancing Care in GI and Biliary Tract Cancers Series Episode 2: HER2 Testing in BTC and GEA 21:49
  21. Advancing Care in GI and Biliary Tract Cancers Series Episode 1: BTC Disease State and Patient Management; Importance of the MDT 26:15
  22. Why First-Line Matters: Survival, Sequencing, and Support in EGFR-Mutated Lung Cancer 29:21
  23. Beyond the Infusion Chair — Care Team Realities in mCRC 20:28
  24. The mCRC Journey Treatment Sequencing and Real-World Decisions 17:36
  25. Younger, Later, Sicker — Changing Faces of Colorectal Cancer 17:22
  26. The Missing Treatment Layer: Daily Support That Improves Treatment Tolerance and Completion 25:50
  27. Inside ESR1: How Mutation Testing Shapes Breast Cancer Care 18:09
  28. From Paper to Practice: FLASCO’s Consensus Paper on Bispecifics Released 23:18
  29. Insights & Understanding of PNH 19:55
  30. Advances in MDS 26:04
  31. New Immunotherapy Options for GE Cancers 11:05
  32. Updates in IDHm Gliomas - Part II 15:46
  33. Updates in IDHm Gliomas - Part I 19:19
  34. Minimal Residual Disease (MRD) Testing 11:53
  35. Updates in Lung Cancer 17:47
  36. Management and Treatment of Polycythemia Vera (PV) 16:49
  37. Welcome to the FLASCO OncoPod with Dr. Maen Hussein 21:34